INDOCONSEIndoco Remedies Limited· PharmaceuticalsHighNeutral
Announced Sat, 30 Aug · 10:30 IST

Indoco Remedies Limited has informed the Exchange about Sale Agreement & Lease Agreement entered on 29th August, 2025 for sale and lease back of part of the Company''s movable properties at its Waluj Facility & CRO

Strategic Transactions View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Indoco Remedies has sold part of its movable properties (machinery/equipment) at its Waluj manufacturing facility in Aurangabad and its AnaCipher CRO in Hyderabad to OPC Asset Solution Pvt. Ltd for Rs. 24.65 crores (including GST). The company has simultaneously leased the same assets back for about 10 years (till 30 September 2035), committing to total lease payments of Rs. 34.89 crores (including taxes) plus a security deposit of Rs. 2.46 crores. OPC Asset Solution is an unrelated party and there is no related-party conflict. The company has clarified that manufacturing and business operations will continue uninterrupted as it will keep using these assets on lease.

Likely market impact

This is essentially an asset-monetisation/financing deal, not a strategic divestment. Shareholders get an immediate Rs. 24.65 crore cash inflow but lock in ~Rs. 34.89 crore of lease outflows over the next decade. Day-to-day operations are unaffected, so expect a neutral-to-mildly-positive market reaction, with the deal providing working-capital flexibility.